The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Influenza and RSV incidence during COVID-19 pandemic—an observational study from in-hospital point-of-care testing
Open accessAbstract
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has forced the implementation of unprecedented public health measures strategies which might also have a significant impact on the spreading of other viral pathogens such as influenza and Respiratory Syncytial Virus (RSV) . The present study compares the incidences of the most relevant respiratory viruses before and during the SARS-CoV-2 pandemic in emergency room patients. We analyzed the results of in total 14,946 polymerase chain reaction point-of-care tests (POCT-PCR) for Influenza A, Influenza B, RSV and SARS-CoV-2 in an adult and a pediatric emergency room between December 1, 2018 and March 31, 2021. Despite a fivefold increase in the number of tests performed, the positivity rate for Influenza A dropped from 19.32% (165 positives of 854 tests in 2018/19), 14.57% (149 positives of 1023 in 2019–20) to 0% (0 positives of 4915 tests) in 2020/21. In analogy, the positivity rate for Influenza B and RSV dropped from 0.35 to 1.47%, respectively, 10.65–21.08% to 0% for both in 2020/21. The positivity rate for SARS-CoV2 reached 9.74% (110 of 1129 tests performed) during the so-called second wave in December 2020. Compared to the two previous years, seasonal influenza and RSV incidence was eliminated during the COVID-19 pandemic. Corona-related measures and human behavior patterns could lead to a significant decline or even complete suppression of other respiratory viruses such as influenza and RSV.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These results suggest that public health measures for COVID-19 and mask wearing might have helped to prevent tuberculosis transmission, as observed with influenza95 and respiratory syncytial virus.96”
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dexamethasone in Hospitalized Patients with Covid-19
The RECOVERY Collaborative Group (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2021436 · Cited by 11,477
Remdesivir for the Treatment of Covid-19 — Final Report
Beigel, J. H., Tomashek, K. M., Dodd, L. E., Mehta, A. K., Zingman, B. S., Kalil, A. C., Hohmann, E., Chu, H. Y., Luetkemeyer, A., Kline, S., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007764 · Cited by 7,267
Estimates of global seasonal influenza-associated respiratory mortality: a modelling study
Iuliano, A. D., Roguski, K. M., Chang, H. H., Muscatello, D. J., Palekar, R., Tempia, S., Cohen, C., Gran, J. M., Schanzer, D., Cowling, B. J., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(17)33293-2 · Cited by 3,019
Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
WHO Solidarity Trial Consortium (2021) · New England Journal of Medicine · doi:10.1056/nejmoa2023184 · Cited by 2,745
Wilder-Smith, A., & Freedman, D. O. (2020) · Journal of Travel Medicine · doi:10.1093/jtm/taaa020 · Cited by 2,727
Shi, T., McAllister, D. A., O'Brien, K. L., Simoes, E. A. F., Madhi, S. A., Gessner, B. D., Polack, F. P., Balsells, E., Acacio, S., Aguayo, C., et al. (2017) · The Lancet · doi:10.1016/s0140-6736(17)30938-8 · Cited by 2,371
Troeger, C., Blacker, B., Khalil, I. A., Rao, P. C., Cao, J., Zimsen, S. R. M., Albertson, S. B., Deshpande, A., Farag, T., Abebe, Z., et al. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30310-4 · Cited by 1,968
Real-Time PCR in Clinical Microbiology: Applications for Routine Laboratory Testing
Espy, M. J., Uhl, J. R., Sloan, L. M., Buckwalter, S. P., Jones, M. F., Vetter, E. A., Yao, J. D. C., Wengenack, N. L., Rosenblatt, J. E., Cockerill, F. R., et al. (2006) · Clinical Microbiology Reviews · doi:10.1128/cmr.19.1.165-256.2006 · Cited by 1,318
Comparing SARS-CoV-2 with SARS-CoV and influenza pandemics
Petersen, E., Koopmans, M., Go, U., Hamer, D. H., Petrosillo, N., Castelli, F., Storgaard, M., Al Khalili, S., & Simonsen, L. (2020) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(20)30484-9 · Cited by 1,205
Repurposed antiviral drugs for COVID-19 –interim WHO SOLIDARITY trial resultsPreprint
Pan, H., Peto, R., Karim, Q. A., et al. (2020) · medRxiv · doi:10.1101/2020.10.15.20209817 · Cited by 634
Cited by
Respiratory Syncytial Virus Prefusion F Protein Vaccine in Older Adults
Papi, A., Ison, M. G., Langley, J. M., Lee, D.-G., Leroux-Roels, I., Martinon-Torres, F., Schwarz, T. F., van Zyl-Smit, R. N., Campora, L., Dezutter, N., et al. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2209604 · Cited by 774
The effects of the COVID-19 pandemic on community respiratory virus activity
Chow, E. J., Uyeki, T. M., & Chu, H. Y. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00807-9 · Cited by 651
Kyu, H. H., Vongpradith, A., Sirota, S. B., Novotney, A., Troeger, C. E., Doxey, M. C., Bender, R. G., Ledesma, J. R., Biehl, M. H., Albertson, S. B., et al. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00510-2 · Cited by 330
“54,55 With the relaxation of measures, some countries started to see a rebound in influenza and respiratory syncytial virus infections in late 2020.”
Ledesma, J. R., Ma, J., Zhang, M., Basting, A. V. L., Chu, H. T., Vongpradith, A., Novotney, A., LeGrand, K. E., Xu, Y. Y., Dai, X., et al. (2024) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(24)00007-0 · Cited by 146
The Impact of the COVID-19 Pandemic on Respiratory Syncytial Virus Infection: A Narrative Review
Chuang, Y.-C., Lin, K., Wang, L. Y., Yeh, T.-K., & Liu, P. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s396434 · Cited by 152
“In Germany, similarly, the RSV positivity rate dropped from 10–21% to 0% in the 2020/21 season until the end of March 2021.(31,32) In Nordic countries, RSV has a biennial epidemiological pattern.”
Metadata
- Authors
- Stamm, P., Sagoschen, I., Weise, K., Plachter, B., Münzel, T., Gori, T., & Vosseler, M.
- Affiliations
- University Medical Center of the Johannes Gutenberg University Mainz (DE)
- Corresponding author
- Stamm, Paul
- Venue
- Medical Microbiology and Immunology
- Published
- 2021-10-04
- Volume
- 210
- Issue
- 5-6
- Pages
- 277-282
- ISSN
- 0044-3077 (ISSN-L)
- 0300-8584
- 1432-1831
- PMC
- PMC8487758
- OpenAlex
- W3203240491
- Cited by
- 82
- References
- 28
- Citations by year
- 2026: 3 · 2025: 14 · 2024: 25 · 2023: 22 · 2022: 18
- FWCI
- 11.71
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Medical Microbiology and Immunology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Informationszentrum Lebenswissenschaften (ZB MED) (submittedVersion, cc-by)
- Gutenberg Open Science (submittedVersion, cc-by-nd)
- Gutenberg Open Science (cc-by)
- Funders
- Universitätsmedizin der Johannes Gutenberg-Universität Mainz
- Topics
- Health Sciences › Medicine › Epidemiology › Respiratory viral infections research
- Health Sciences › Medicine › Epidemiology › Influenza Virus Research Studies
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- COVID-19 pandemic, influenza A virus, influenza B, respiratory syncytial virus, SARS-CoV-2, emergency department patients, positivity rate, public health measures, pediatric patients
- MeSH terms
- Point-of-Care Testing, COVID-19, Hospitals, Humans, Influenza, Human, Orthomyxoviridae, Retrospective Studies, Incidence, Polymerase Chain Reaction, Respiratory Syncytial Virus, Human, Respiratory Syncytial Virus Infections, Pandemics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Influenza and RSV incidence during COVID-19 pandemic—an observational study from in-hospital point-of-care testing. https://app.cochat.ai/papers/10.1007/s00430-021-00720-7
- The paper
- Stamm, P., Sagoschen, I., Weise, K., Plachter, B., Münzel, T., Gori, T., & Vosseler, M. (2021). Influenza and RSV incidence during COVID-19 pandemic—an observational study from in-hospital point-of-care testing. Medical Microbiology and Immunology. https://doi.org/10.1007/s00430-021-00720-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.